- Home
- ALDX vs RMNI Comparison
ALDX vs RMNI Comparison
Compare ALDX & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- RMNI
- Stock Information
- Founded
- ALDX 2004
- RMNI 2005
- Country
- ALDX United States
- RMNI United States
- Employees
- ALDX N/A
- RMNI N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- RMNI Business Services
- Sector
- ALDX Health Care
- RMNI Consumer Discretionary
- Exchange
- ALDX Nasdaq
- RMNI Nasdaq
- Market Cap
- ALDX 342.3M
- RMNI 400.6M
- IPO Year
- ALDX 2014
- RMNI N/A
- Fundamental
- Price
- ALDX $5.09
- RMNI $4.59
- Analyst Decision
- ALDX Strong Buy
- RMNI Strong Buy
- Analyst Count
- ALDX 2
- RMNI 1
- Target Price
- ALDX $9.50
- RMNI $6.00
- AVG Volume (30 Days)
- ALDX 776.7K
- RMNI 287.9K
- Earning Date
- ALDX 11-06-2025
- RMNI 10-29-2025
- Dividend Yield
- ALDX N/A
- RMNI N/A
- EPS Growth
- ALDX N/A
- RMNI N/A
- EPS
- ALDX N/A
- RMNI N/A
- Revenue
- ALDX N/A
- RMNI $427,203,000.00
- Revenue This Year
- ALDX N/A
- RMNI $0.60
- Revenue Next Year
- ALDX $63.48
- RMNI $4.01
- P/E Ratio
- ALDX N/A
- RMNI N/A
- Revenue Growth
- ALDX N/A
- RMNI N/A
- 52 Week Low
- ALDX $1.14
- RMNI $1.53
- 52 Week High
- ALDX $7.20
- RMNI $5.38
- Technical
- Relative Strength Index (RSI)
- ALDX 37.78
- RMNI 59.59
- Support Level
- ALDX $5.48
- RMNI $4.47
- Resistance Level
- ALDX $5.88
- RMNI $4.88
- Average True Range (ATR)
- ALDX 0.29
- RMNI 0.19
- MACD
- ALDX -0.10
- RMNI 0.03
- Stochastic Oscillator
- ALDX 10.63
- RMNI 61.84
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About RMNI Rimini Street Inc. (DE)
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.